T Okugawa Selected Research

T Okugawa Research Topics

6	Neoplasms (Cancer) 02/2008 - 01/2000
1	Dyspepsia (Indigestion) 01/2012
1	Hypersensitivity (Allergy) 01/2012
1	Bacterial Infections (Bacterial Infection) 02/2010
1	Endometrial Neoplasms (Endometrial Cancer) 02/2008
1	Uterine Hemorrhage (Uterine Bleeding) 02/2008
1	Carcinoma (Carcinomatosis) 01/2008
1	Ovarian Epithelial Carcinoma 01/2008
1	Diverticulum 01/2003
1	Hematuria 08/2001
1	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2001
1	Proteinuria 08/2001
1	Ovarian Neoplasms (Ovarian Cancer) 11/2000
1	Pulmonary Embolism 10/2000
1	Thrombosis (Thrombus) 10/2000
1	Non-gestational Choriocarcinoma (Choriocarcinoma, Non gestational) 08/2000

3	Peptides (Polypeptides)IBA 11/2000 - 01/2000
2	AntigensIBA 11/2000 - 08/2000
1	AcidsIBA 01/2012
1	NucleotidesIBA 02/2010
1	Peptidoglycan (Murein)IBA 02/2010
1	Carboplatin (JM8)FDA LinkGeneric 01/2008
1	Complement System Proteins (Complement)IBA 08/2001
1	CreatinineIBA 08/2001
1	HER2p63 peptideIBA 11/2000
1	AutoantigensIBA 11/2000
1	fibrin fragment D (D-dimer)IBA 10/2000
1	antithrombin III-protease complexIBA 10/2000
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2000
1	AntithrombinsIBA 10/2000
1	Fibrin Fibrinogen Degradation ProductsIBA 10/2000
1	Fibrinogen (Factor I)FDA Link 10/2000
1	Hemostatics (Antihemorrhagics)IBA 10/2000
1	Protein CIBA 10/2000
1	HER2-neu-derived peptide (780-786)IBA 08/2000
1	peptide AIBA 08/2000
1	Complementary DNA (cDNA)IBA 08/2000
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2000
1	VaccinesIBA 01/2000
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2000

2	Therapeutics 01/2008 - 01/2000
2	Drug Therapy (Chemotherapy) 01/2008 - 08/2000
1	Vacuum Curettage 02/2008
1	Salpingo-oophorectomy 01/2008
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2003